CUBT (Curative Biotechnology) Other Current Liabilities: $0.03 Mil (As of Mar. 2023)


What is Curative Biotechnology Other Current Liabilities?

Curative Biotechnology CUBT Other Current Liabilities is $0.03 Mil as of Mar. 2023.

Curative Biotechnology's other current liabilities for the quarter that ended in Mar. 2023 was $0.03 Mil.

Curative Biotechnology's quarterly other current liabilities increased from Sep. 2022 ($0.01 Mil) to Dec. 2022 ($0.02 Mil) and increased from Dec. 2022 ($0.02 Mil) to Mar. 2023 ($0.03 Mil).

Curative Biotechnology's annual other current liabilities declined from Dec. 2020 ($0.01 Mil) to Dec. 2021 ($0.00 Mil) but then increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.02 Mil).

Curative Biotechnology Other Current Liabilities Related Terms

Curative Biotechnology Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Curative Biotechnology's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biotechnology Other Current Liabilities Chart

Curative Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Liabilities
Get a 7-Day Free Trial -0.00 0.00 0.01 0.00 0.02

Curative Biotechnology Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.01 0.01 0.02 0.03

Curative Biotechnology Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.03 Mil mean?
Curative Biotechnology (CUBT) has a Other Current Liabilities of $0.03 Mil as of Mar. 2023. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Curative Biotechnology.
Is Curative Biotechnology's Other Current Liabilities too high?
Curative Biotechnology's current Other Current Liabilities is $0.03 Mil.
How does Curative Biotechnology's Other Current Liabilities compare to ORGS and SNSE?
Curative Biotechnology's Other Current Liabilities of $0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Curative Biotechnology. Curative Biotechnology's current Other Current Liabilities is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biotechnology stock overvalued right now?
Curative Biotechnology (CUBT) has a current Other Current Liabilities of $0.03 Mil. The current Other Current Liabilities is $0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Curative Biotechnology (CUBT), the current Other Current Liabilities is $0.03 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biotechnology Business Description

Address 3801 PGA Boulevard, Suite 600, Palm Beach Gardens, FL, USA, 33410
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The Company is identifying, acquiring, and developing disease-modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biotech currently has ongoing programs in three different therapeutic areas: degenerative eye disease, infectious disease, and neuro-oncology. The Company is now concentrating its energy and resources on its degenerative eye disease platform.